Add-on Low Dose Dextromethorphan and Memantine in Patients With Amphetamine-type Stimulants Use Disorder
Status:
Completed
Trial end date:
2020-08-31
Target enrollment:
Participant gender:
Summary
The current study will investigate whether add-on dextromethorphan (DM) and memantine (MM) is
able to improve the treatment outcomes for ATSUD, and be associated with improvement in
inflammatory markers, neurotrophic factors and neuropsychological tests.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Tzu-Yun Wang
Collaborator:
Ministry of Science and Technology, Taiwan
Treatments:
Amphetamine Central Nervous System Stimulants Dextromethorphan Memantine